Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To determine the safety and tolerability of orally administered hydroxychloroquine with
hormonal therapy.
To assess the response rate of hydroxychloroquine in combination with hormonal therapy.